Binding of Trastuzumab to ErbB2 Is Inhibited by a High Pericellular Density of Hyaluronan
出版年份 2012 全文链接
标题
Binding of Trastuzumab to ErbB2 Is Inhibited by a High Pericellular Density of Hyaluronan
作者
关键词
-
出版物
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
Volume 60, Issue 8, Pages 567-575
出版商
SAGE Publications
发表日期
2012-05-06
DOI
10.1369/0022155412448070
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo
- (2011) Hiroshi Urakawa et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibition of Oesophageal Squamous Cell Carcinoma Progression by in vivo Targeting of Hyaluronan Synthesis
- (2011) Sören Twarock et al. Molecular Cancer
- Biological hydrogels as selective diffusion barriers
- (2011) Oliver Lieleg et al. TRENDS IN CELL BIOLOGY
- Mechanisms of resistance to anti-human epidermal growth factor receptor 2 agents in breast cancer
- (2010) Toru Mukohara CANCER SCIENCE
- Quantitation of p95HER2 in Paraffin Sections by Using a p95-Specific Antibody and Correlation with Outcome in a Cohort of Trastuzumab-Treated Breast Cancer Patients
- (2010) J. Sperinde et al. CLINICAL CANCER RESEARCH
- Hyaluronan in human malignancies
- (2010) R.K. Sironen et al. EXPERIMENTAL CELL RESEARCH
- Calpain-1 expression is associated with relapse-free survival in breast cancer patients treated with trastuzumab following adjuvant chemotherapy
- (2010) Sarah J. Storr et al. INTERNATIONAL JOURNAL OF CANCER
- Enzymatic Depletion of Tumor Hyaluronan Induces Antitumor Responses in Preclinical Animal Models
- (2010) C. B. Thompson et al. MOLECULAR CANCER THERAPEUTICS
- Management of breast cancer with targeted agents: importance of heterogenicity
- (2010) Serena Di Cosimo et al. Nature Reviews Clinical Oncology
- Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941
- (2009) Teemu T. Junttila et al. CANCER CELL
- ErbB receptors and signaling pathways in cancer
- (2009) Nancy E Hynes et al. CURRENT OPINION IN CELL BIOLOGY
- Validation of the 4B5 rabbit monoclonal antibody in determining Her2/neu status in breast cancer
- (2009) Bert van der Vegt et al. MODERN PATHOLOGY
- HER-2/neu expression in primary and metastatic breast cancer
- (2008) Elyse E. Lower et al. BREAST CANCER RESEARCH AND TREATMENT
- EGFR and ErbB2 are functionally coupled to CD44 and regulate shedding, internalization and motogenic effect of CD44
- (2008) Zsuzsanna Pályi-Krekk et al. CANCER LETTERS
- Oncogene Addiction
- (2008) I. B. Weinstein et al. CANCER RESEARCH
- Targeted therapies in breast cancer: Where are we now?
- (2008) Serena Di Cosimo et al. EUROPEAN JOURNAL OF CANCER
- The role of Neuregulin-1β/ErbB signaling in the heart
- (2008) Laura Pentassuglia et al. EXPERIMENTAL CELL RESEARCH
- Pericellular Hyaluronan Coat Visualized in Live Cells With a Fluorescent Probe Is Scaffolded by Plasma Membrane Protrusions
- (2008) Kirsi Rilla et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Altered hyaluronan biosynthesis in cancer progression
- (2008) Naoki Itano et al. SEMINARS IN CANCER BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started